ResearchGene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy
ResearchModernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health Collaboration
ResearchGene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies
ResearchCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma
ResearchHigh-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance
ResearchOpportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration
ResearchThe Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposals
ResearchGene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy